Promising ultrasound therapy for Alzheimer’s disease licensed to new start-up

A promising ultrasound therapy to potentially restore brain function in people with Alzheimer’s disease has been licenced to a new start-up spun out of The University of Queensland.

J&J’s Megadyne restricts use of electrodes over burn risk, triggering Class I FDA notice

Dive Brief: The Food and Drug Administration has categorized an urgent medical device correction from Johnson & Johnson’s Megadyne as a Class I event. Megadyne

January 9, 2024

Opinion | Fauci Facepalms Won’t Cut It in the Second Trump Administration

Oxman is an intensive care physician and associate professor of medicine. It was one of the more memorable images of the COVID pandemic. Anthony Fauci,

December 3, 2024

Signal: Tweets of the week focus on Eli Lilly’s most recent acquisitions – Pharmaceutical Technology

Eli Lilly is enlarging its drug pipeline with major acquisitions following second quarter financial statements. Image credit: kenary820 / Shutterstock Eli Lilly continues to make

August 17, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.